Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancer D. W. VisscherS. WykesJ. D. Crissman Report Pages: 111 - 118
Genetic evolution of breast cancer: II. relationship with estrogen and progesterone receptor expression H. MagdelenatM. Gerbault-SeureauB. Dutrillaux Report Pages: 119 - 127
Weight gain after primary surgery for breast cancer - effect of tamoxifen Peter J. HoskinSue AshleyJohn R. Yarnold Report Pages: 129 - 132
1α-hydroxyvitamin D3, hypercalcemia, and growth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors Yuichi IinoMasao YoshidaYasuo Morishita Report Pages: 133 - 140
Epidermal growth factor receptor in breast cancer: Storage conditions affecting measurement, and relationship to steroid receptors W. R. B. McLeayD. J. HorsfallG. T. P. Saccone Report Pages: 141 - 151
Tamoxifen metabolism is altered by simultaneous administration of medroxyprogesterone acetate in breast cancer patients Angus D. ReidJean M. HorobinPaul E. Preece Brief Communication Pages: 153 - 156
Regulation of estrogen sulfotransferase by estrogen in MCF-7 human mammary cancer cells John B. AdamsRobertos VrahimisNarelle Phillips Brief Communication Pages: 157 - 161
U.K. National Breast Screening Programme: First year experience at a histopathology department in an assessment/treating centre Sami Shousha Correspondence Pages: 177 - 179
Comment on ‘Breast deformity, its correction, and assessment of breast conserving surgery’ Neal HandelMasakuni Noguchi Correspondence Pages: 181 - 182